Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics is dedicated to developing medications for immune-mediated diseases. They target the inhibition of inflammatory cells associated with ocular and systemic ailments. Their focus is on developing next-generation medicines for unmet needs. They have investigational therapies in late-stage clinical testing.
Offizielles Register
Zuletzt überprüft: 12/30/2025
KI-Qualitätsanalyse
Vertrauensscore-Details
Schnellzugriff
Website-Highlights
🌟 Ähnliche vertrauenswürdige Unternehmen
BRISTOL MYERS SQUIBB CO
Bristol Myers Squibb (BMS) is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines. Their key products and services include treatments for cancer, cardiovascular disease, immunology, and other serious diseases. BMS is positioned as a leading company in the pharmaceutical industry, with a commitment to research and development to improve patient outcomes.
TG THERAPEUTICS, INC.
TG Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Their lead product, BRIUMVI® (ublituximab-xiiy), is approved for the treatment of relapsing forms of multiple sclerosis (MS). The company is dedicated to research and development within these therapeutic areas.